Key result
Early ImpellaCP prevents hemodynamic instability and bridges to surgery in 2 AMI patients with VSD.
Why the study?
Mechanical support with Impella has been described in ischaemic ventricular septal defect, but its early use to prevent haemodynamic instability while deferring surgical repair warranted description.
Does early ImpellaCP implantation improve haemodynamic stability and allow bridging to delayed surgical repair in patients with acute myocardial infarction complicated by ventricular septal defect?
Case Report (n=2)
Does early ImpellaCP implantation improve haemodynamic stability and allow bridging to delayed surgical repair in patients with acute myocardial infarction complicated by ventricular septal defect?
Early ImpellaCP implantation may provide effective ventricular unloading and hemodynamic stabilization in post-MI VSD, facilitating delayed surgical repair beyond the high-risk acute phase.
Answers are grounded in this paper and cite their sources.
May support early ImpellaCP stabilization in post-MI VSD; hypothesis-generating and leaves open prospective validation.
Despite a relative contraindication, mechanical support with Impella™ left ventricular assist device has already been described for ischaemic ventricular septal defect treatment, either as a bridge to surgery, as intraoperative mechanical haemodynamic support, or to ensure intraprocedural haemodynamic stability during device closure. We describe two cases of ventricular septal defect complicating acute myocardial infarction, where the percutaneous ImpellaCP was implanted early (differently than previously described) with the aim of preventing haemodynamic instability, while deferring surgical repair. We present a report of haemodynamic, echocardiographic, biochemical, and clinical data of two consecutive cases of ImpellaCP use, within a minimally invasive monitoring and therapeutic approach. In two cases of subacute myocardial infarction-related ventricular septal defect not amenable to percutaneous device closure, the use ImpellaCP was successful: it was followed by effective and rapid right and left ventricular unloading, by major haemodynamic instability prevention and protection from systemic venous congestion, from kidney and splanchnic organ failures. This allowed bridging to appropriately timed surgical repair. These cases suggest a potentially effective, clinically grounded strategy in the early management of ischaemic ventricular septal defect patients, with the aim of deferring surgery beyond the safer 7 days cutoff associated with a lower perioperative mortality.
No takes yet. Share an insight, caveat, or question.
Via et al. (2020) conducted a case report in Acute myocardial infarction with ventricular septal defect (n=2). ImpellaCP was evaluated on Haemodynamic stability and bridging to surgical repair. Early implantation of ImpellaCP in 2 patients with acute myocardial infarction and ventricular septal defect successfully prevented haemodynamic instability and allowed bridging to surgical repair.
Synapse has enriched 10 related papers. Consider them for comparative context: